A61P 25/02
Drugs for disorders of the nervous system: for peripheral neuropathies
Official title: for peripheral neuropathies
A61P25/02 (Drugs for disorders of the nervous system: for peripheral neuropathies) appears on 7,113 US grants and 10,162 published applications in this corpus.
Search patents in A61P- Granted patents
- 7,113
- Published applications
- 10,162
- Assignees
- 3,025
- Inventors
- 17,884
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 11 | 0 |
| 1978 | 19 | 0 |
| 1979 | 19 | 0 |
| 1980 | 24 | 0 |
| 1981 | 33 | 0 |
| 1982 | 27 | 0 |
| 1983 | 19 | 0 |
| 1984 | 27 | 0 |
| 1985 | 42 | 0 |
| 1986 | 36 | 0 |
| 1987 | 35 | 0 |
| 1988 | 48 | 0 |
| 1989 | 49 | 0 |
| 1990 | 49 | 0 |
| 1991 | 69 | 0 |
| 1992 | 43 | 0 |
| 1993 | 28 | 0 |
| 1994 | 43 | 0 |
| 1995 | 54 | 0 |
| 1996 | 66 | 0 |
| 1997 | 81 | 0 |
| 1998 | 75 | 0 |
| 1999 | 69 | 0 |
| 2000 | 72 | 0 |
| 2001 | 85 | 42 |
| 2002 | 101 | 214 |
| 2003 | 150 | 375 |
| 2004 | 110 | 491 |
| 2005 | 125 | 496 |
| 2006 | 174 | 529 |
| 2007 | 222 | 515 |
| 2008 | 239 | 564 |
| 2009 | 276 | 653 |
| 2010 | 381 | 725 |
| 2011 | 375 | 569 |
| 2012 | 428 | 517 |
| 2013 | 428 | 415 |
| 2014 | 410 | 508 |
| 2015 | 378 | 428 |
| 2016 | 324 | 438 |
| 2017 | 342 | 441 |
| 2018 | 273 | 384 |
| 2019 | 274 | 374 |
| 2020 | 225 | 309 |
| 2021 | 187 | 260 |
| 2022 | 164 | 215 |
| 2023 | 94 | 190 |
| 2024 | 137 | 192 |
| 2025 | 96 | 200 |
| 2026 | 63 | 118 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions useful for treatment of Charcot-Marie-Tooth disease6 Oct 2026US 12,753,419 B2The Trustees of the University of Pennsylvania
- Methods for treating bone and neuropathic pain with capsaicin15 Sep 2026US 12,734,140 B1
- Methods for treating symptoms and disorders associated with lysosomal storage diseases15 Sep 2026US 12,734,160 B2Genzyme Corporation
- Piperidine urea derivatives for cancer therapy15 Sep 2026US 12,734,164 B2NeuroPn Therapeutics, Inc.
- Treatment of CNS disorders with sleep disturbances25 Aug 2026US 12,714,683 B2University of Copenhagen
- Cannabinoid-based formulation8 Oct 2026US 2026/0306516 A1
- Treatment of pain8 Oct 2026US 2026/0306596 A1Ipsen Biopharm Ltd.
- Compositions and methods for treatment of neurological disorders8 Oct 2026US 2026/0308614 A1Board of Regents, The University of Texas System
- Compositions and method for management of pain and allergy24 Sep 2026US 2026/0284003 A1
- Zinc finger protein transcription factors for repressing nav1.7 expression24 Sep 2026US 2026/0285923 A1Sangamo Therapeutics, Inc.
Most cited
By later US patents
- Biocompatible devices with foam scaffolds984US 6,054,142 ACyto Therapeutics, Inc. · 2000
- Delivery of multiple doses of medications377US 5,837,284 A1998
- Bioadhesive extruded film for intra-oral drug delivery and process375US 4,713,243 AJohnson & Johnson Products, Inc. · 1987
- Biocompatible devices with foam scaffolds353US 6,231,879 B1Neurotech S.A. · 2001
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009